Rbf Capital »

Oramed Pharm shares owned by Rbf Capital

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Rbf Capital from 13F filings

Historical chart of Rbf Capital investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Rbf Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Rbf Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $113k 43k 2.64
2025-06-30 $97k 43k 2.25
2025-03-31 $92k 43k 2.14

More positions owned by Rbf Capital

Morgan Stanley Com New Put Option (MS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Applovin Corp Com Cl A (APP)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Bank of America Corporation (BAC)
Danaos Corporation SHS (DAC)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Visa Com Cl A (V)
Hca Holdings (HCA)
Builders FirstSource (BLDR)
Apple (AAPL)
Fair Isaac Corporation (FICO)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Rbf Capital

Top funds holding Oramed Pharm

BML Capital Management
Murchinson
Boothbay Fund Management
Rathbones Brothers
Renaissance Technologies
Dimensional Fund Advisors
Wells Fargo & Company
Citadel Advisors
BlackRock
Jane Street
Rbf Capital
Susquehanna International
Morgan Stanley
Squarepoint Ops
Connor, Clark & Lunn Investment Management

View all funds holding Oramed Pharm